Logo image of FEAM

5E ADVANCED MATERIALS INC (FEAM) Stock Fundamental Analysis

NASDAQ:FEAM - Nasdaq - US33830Q2084 - Common Stock - Currency: USD

3.2132  +0.16 (+5.35%)

Fundamental Rating

1

FEAM gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 157 industry peers in the Metals & Mining industry. FEAM has a bad profitability rating. Also its financial health evaluation is rather negative. FEAM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year FEAM has reported negative net income.
In the past year FEAM has reported a negative cash flow from operations.
FEAM had negative earnings in each of the past 5 years.
In the past 5 years FEAM always reported negative operating cash flow.
FEAM Yearly Net Income VS EBIT VS OCF VS FCFFEAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -51.71%, FEAM is doing worse than 89.81% of the companies in the same industry.
FEAM's Return On Equity of -57.29% is on the low side compared to the rest of the industry. FEAM is outperformed by 83.44% of its industry peers.
Industry RankSector Rank
ROA -51.71%
ROE -57.29%
ROIC N/A
ROA(3y)-64.57%
ROA(5y)-47.91%
ROE(3y)-247.59%
ROE(5y)-158.22%
ROIC(3y)N/A
ROIC(5y)N/A
FEAM Yearly ROA, ROE, ROICFEAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

FEAM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FEAM Yearly Profit, Operating, Gross MarginsFEAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

FEAM has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, FEAM has a worse debt to assets ratio.
FEAM Yearly Shares OutstandingFEAM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
FEAM Yearly Total Debt VS Total AssetsFEAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

FEAM has an Altman-Z score of -1.34. This is a bad value and indicates that FEAM is not financially healthy and even has some risk of bankruptcy.
FEAM has a worse Altman-Z score (-1.34) than 87.26% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that FEAM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, FEAM belongs to the top of the industry, outperforming 84.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.34
ROIC/WACCN/A
WACCN/A
FEAM Yearly LT Debt VS Equity VS FCFFEAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

A Current Ratio of 0.74 indicates that FEAM may have some problems paying its short term obligations.
The Current ratio of FEAM (0.74) is worse than 89.81% of its industry peers.
A Quick Ratio of 0.74 indicates that FEAM may have some problems paying its short term obligations.
FEAM has a worse Quick ratio (0.74) than 80.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
FEAM Yearly Current Assets VS Current LiabilitesFEAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.35% over the past year.
EPS 1Y (TTM)2.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 10.61% on average over the next years. This is quite good.
The Revenue is expected to grow by 85.38% on average over the next years. This is a very strong growth
EPS Next Y79.02%
EPS Next 2Y37.72%
EPS Next 3Y10.61%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-72.78%
Revenue Next 3Y85.38%
Revenue Next 5YN/A

3.3 Evolution

FEAM Yearly Revenue VS EstimatesFEAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2026 2027 2M 4M 6M 8M
FEAM Yearly EPS VS EstimatesFEAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -5 -10 -15 -20 -25

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FEAM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FEAM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FEAM Price Earnings VS Forward Price EarningsFEAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FEAM Per share dataFEAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.72%
EPS Next 3Y10.61%

0

5. Dividend

5.1 Amount

No dividends for FEAM!.
Industry RankSector Rank
Dividend Yield N/A

5E ADVANCED MATERIALS INC

NASDAQ:FEAM (8/4/2025, 1:20:11 PM)

3.2132

+0.16 (+5.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)09-09 2025-09-09/amc
Inst Owners39.58%
Inst Owner Change0.37%
Ins Owners0.03%
Ins Owner Change5.72%
Market Cap64.33M
Analysts82.86
Price Target12.24 (280.93%)
Short Float %0.49%
Short Ratio3.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.23%
Min EPS beat(2)-2.94%
Max EPS beat(2)27.41%
EPS beat(4)2
Avg EPS beat(4)-41.92%
Min EPS beat(4)-194.11%
Max EPS beat(4)27.41%
EPS beat(8)4
Avg EPS beat(8)-19.03%
EPS beat(12)5
Avg EPS beat(12)-26.79%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-58.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10%
EPS NY rev (1m)0%
EPS NY rev (3m)49.18%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-17.07
EYN/A
EPS(NY)-1.95
Fwd EYN/A
FCF(TTM)-1.37
FCFYN/A
OCF(TTM)-1.23
OCFYN/A
SpS0
BVpS3.31
TBVpS3.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.71%
ROE -57.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-64.57%
ROA(5y)-47.91%
ROE(3y)-247.59%
ROE(5y)-158.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.87%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z -1.34
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5445.43%
Cap/Depr(5y)14567.3%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.28%
EPS Next Y79.02%
EPS Next 2Y37.72%
EPS Next 3Y10.61%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-72.78%
Revenue Next 3Y85.38%
Revenue Next 5YN/A
EBIT growth 1Y-66.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.36%
EBIT Next 3Y-0.19%
EBIT Next 5YN/A
FCF growth 1Y58.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.04%
OCF growth 3YN/A
OCF growth 5YN/A